KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Emergent BioSolutions (EBS) Other Gross PP&E Adjustments (2016 - 2025)

Emergent BioSolutions' Other Gross PP&E Adjustments history spans 15 years, with the latest figure at $498.9 million for Q4 2025.

  • For Q4 2025, Other Gross PP&E Adjustments fell 23.95% year-over-year to $498.9 million; the TTM value through Dec 2025 reached $498.9 million, down 23.95%, while the annual FY2025 figure was $498.9 million, 23.95% down from the prior year.
  • Other Gross PP&E Adjustments reached $498.9 million in Q4 2025 per EBS's latest filing, up from $493.3 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $1.2 billion in Q4 2022 to a low of $493.3 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 5 years is $842.9 million, with a median of $782.9 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: increased 26.78% in 2021, then crashed 35.02% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.1 billion in 2021, then rose by 8.35% to $1.2 billion in 2022, then crashed by 34.18% to $778.0 million in 2023, then decreased by 15.68% to $656.0 million in 2024, then fell by 23.95% to $498.9 million in 2025.
  • Per Business Quant, the three most recent readings for EBS's Other Gross PP&E Adjustments are $498.9 million (Q4 2025), $493.3 million (Q3 2025), and $508.0 million (Q2 2025).